Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism.
Burke
G W
GW
University of Miami School of Medicine, Department of Surgery, Florida 33136, USA.
Ricordi
C
C
Karatzas
T
T
Carreno
M
M
Markou
M
M
Cirocco
R
R
Ciancio
G
G
Qian
T
T
Selvaggi
G
G
Alejandro
R
R
Skyler
J S
JS
Roth
D
D
Tzakis
A
A
Miller
J
J
D000328:Adult; D001379:Azathioprine / Q000627:therapeutic use; D016026:Bone Marrow Transplantation / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000601:surgery*; D003928:Diabetic Nephropathies / Q000601:surgery*; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D010179:Pancreas / Q000276:immunology*; D016559:Tacrolimus / Q000627:therapeutic use; D013997:Time Factors; D018183:Transplantation Chimera
D007166:Immunosuppressive Agents; D016853:Muromonab-CD3; D001379:Azathioprine; D016559:Tacrolimus; D008775:Methylprednisolone